For example, high CDK7 expression is associated with favorable prognosis in adrenocortical carcinoma (ACC) and high CDK9 expression with favorable prognosis in pancreatic adenocarcinoma (PAAD) and low-grade glioma (LGG) (Fig. 1d,e). This evidence concerns the gene CDK7 and central nervous system cancer.